Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Nieber, C. Baumgarten, R. Rathsack, J. Furkert, E. Laake, S. Müller, G. Kunkel (1993)
Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthmaClinical & Experimental Allergy, 23
W. Berger, J. Bousquet, A. Fox, J. Just, A. Muraro, A. Nieto, E. Valovirta, M. Wickman, U. Wahn (2016)
MP‐AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in childrenAllergy, 71
J. Bousquet, C. Bachert, G. Canonica, J. Mullol, P. Cauwenberge, C. Jensen, W. Fokkens, J. Ring, P. Keith, R. Lorber, T. Zuberbier (2009)
Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN studyAllergy, 64
Dimitri Tränkner, Nadeau Hahne, Ken Sugino, M. Hoon, C. Zuker (2014)
Population of sensory neurons essential for asthmatic hyperreactivity of inflamed airwaysProceedings of the National Academy of Sciences, 111
R. Salib, Philip Harries, S. Nair, Peter Howarth (2008)
Mechanisms and mediators of nasal symptoms in non‐allergic rhinitisClinical & Experimental Allergy, 38
M. Shin, F. Baroody, D. Proud, A. Kagey-sobotka, L. Lichtenstein, R. Naclerio (1992)
The effect of azelastine on the early allergic responseClinical & Experimental Allergy, 22
L. Klimek, C. Bachert, R. Mösges, U. Munzel, D. Price, J. Virchow, U. Wahn, J. Bousquet (2015)
Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.Allergy and asthma proceedings, 36 1
D. Kempuraj, Man Huang, K. Kandere-Grzybowska, S. Basu, W. Boucher, R. Letourneau, A. Athanassiou, T. Theoharides (2003)
Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells.International archives of allergy and immunology, 132 3
M. Holm, H. Andersen, T. Hetland, C. Dahl, H. Hoffmann, S. Junker, P. Schiøtz (2008)
Seven week culture of functional human mast cells from buffy coat preparations.Journal of immunological methods, 336 2
Y. Alpizar, M. Gees, Alicia Sánchez, A. Apetrei, T. Voets, B. Nilius, K. Talavera (2013)
Bimodal effects of cinnamaldehyde and camphor on mouse TRPA1Pflügers Archiv - European Journal of Physiology, 465
Michael Lytinas, D. Kempuraj, Man Huang, K. Kandere, W. Boucher, R. Letourneau, Sheila Jeudy, K. Fitzgerald, K. Spear, A. Athanasiou, T. Theoharides (2002)
Azelastine's inhibition of histamine and tryptase release from human umbilical cord blood-derived cultured mast cells as well as rat skin mast cell-induced vascular permeability: comparison with olopatadine.Allergy and asthma proceedings, 23 1
E. Meltzer, C. Laforce, P. Ratner, D. Price, D. Ginsberg, W. Carr (2012)
MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.Allergy and asthma proceedings, 33 4
I. Krohn, A. Sverrild, G. Lund, R. Dahl, J. Erjefält, V. Backer, H. Hoffmann (2013)
Cultured Mast Cells from Patients with Asthma and Controls Respond with Similar Sensitivity to Recombinant Der P2‐Induced, IgE‐Mediated ActivationScandinavian Journal of Immunology, 78
INTEREST The author's laboratories are supported by grants from IWT (TBM project 130260) and the research council of the KU Leuven (GOA 2009/07 and 14/011)
Hiroto Akabane, M. Murata, Masafumi Kubota, E. Takashima, Hiroyuki Tanaka, N. Inagaki, M. Horiba, H. Nagai (2006)
Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells.Allergology international : official journal of the Japanese Society of Allergology, 55 4
L. Klimek, J. Bousquet, D. Price (2016)
Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitisExpert Opinion on Drug Safety, 15
S. Talbot, R. Abdulnour, P. Burkett, Seungkyu Lee, Shane Cronin, Maud Pascal, C. Laedermann, Simmie Foster, Johnathan Tran, N. Lai, I. Chiu, N. Ghasemlou, Matthew Dibiase, David Roberson, C. Hehn, Busranour Agac, O. Haworth, H. Seki, J. Penninger, V. Kuchroo, B. Bean, B. Levy, C. Woolf (2015)
Silencing Nociceptor Neurons Reduces Allergic Airway InflammationNeuron, 87
H. Kleij, D. Ma, F. Redegeld, A. Kraneveld, F. Nijkamp, J. Bienenstock (2003)
Functional Expression of Neurokinin 1 Receptors on Mast Cells Induced by IL-4 and Stem Cell Factor1The Journal of Immunology, 171
L. Gerven, Guy Boeckxstaens, P. Hellings (2012)
Up-date on neuro-immune mechanisms involved in allergic and non-allergic rhinitis.Rhinology, 50 3
D. Kempuraj, Man Huang, K. Kandere-Grzybowska, S. Basu, W. Boucher, R. Letourneau, A. Athanassiou, T. Theoharides (2003)
Azelastine Inhibits Secretion of IL-6, TNF-α and IL-8 as well as NF-κB Activation and Intracellular Calcium Ion Levels in Normal Human Mast CellsInternational Archives of Allergy and Immunology, 132
Mylan company, for the unrestricted research grant for clinical research
H. Derendorf, E. Meltzer, R. Hermann, G. Canonica (2014)
Clinical development of an advanced intranasal delivery system of azelastine hydrochloride and fluticasone propionate.Drugs of today, 50 1
J. Bousquet, C. Bachert, J. Bernstein, G. Canonica, W. Carr, R. Dahl, P. Demoly, P. Devillier, P. Hellings, W. Fokkens, L. Klimek, P. Lieberman, E. Meltzer, D. Price, D. Ryan, U. Wahn (2015)
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gapsExpert Opinion on Pharmacotherapy, 16
P. Demoly, P. Bousquet, K. Mesbah, J. Bousquet, P. Devillier (2013)
Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary careClinical & Experimental Allergy, 43
G. Story, A. Peier, A. Reeve, S. Eid, J. Mosbacher, Todd Hricik, Taryn Earley, A. Hergarden, D. Andersson, S. Hwang, P. McIntyre, T. Jegla, S. Bevan, A. Patapoutian (2003)
ANKTM1, a TRP-like Channel Expressed in Nociceptive Neurons, Is Activated by Cold TemperaturesCell, 112
M. Wouters, Dafne Balemans, S. Wanrooy, J. Dooley, V. Cibert-Goton, Y. Alpizar, Eduardo Valdez-Moráles, Y. Nasser, P. Veldhoven, Winde Vanbrabant, S. Merwe, R. Mols, B. Ghesquière, C. Cirillo, I. Kortekaas, P. Carmeliet, W. Peetermans, S. Vermeire, P. Rutgeerts, P. Augustijns, P. Hellings, A. Belmans, S. Vanner, D. Bulmer, K. Talavera, P. Berghe, A. Liston, G. Boeckxstaens (2016)
Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.Gastroenterology, 150 4
A. Takao, T. Shimoda, H. Matsuse, K. Mitsuta, Y. Obase, Sadahiro Asai, Shigeru Kohno (1999)
Inhibitory effects of azelastine hydrochloride in alcohol-induced asthma.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 82 4
V. Meseguer, Bristol Denlinger, K. Talavera (2011)
Methodological considerations to understand the sensory function of TRP channels.Current pharmaceutical biotechnology, 12 1
W. Berger, Shailen Shah, P. Lieberman, J. Hadley, D. Price, U. Munzel, S. Bhatia (2014)
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis.The journal of allergy and clinical immunology. In practice, 2 2
V. Hox, J. Vanoirbeek, Y. Alpizar, Sabrina Voedisch, I. Callebaut, S. Bobic, A. Sharify, V. Vooght, L. Gerven, F. Devos, A. Liston, T. Voets, R. Vennekens, D. Bullens, A. Vries, P. Hoet, A. Braun, J. Ceuppens, K. Talavera, B. Nemery, P. Hellings (2013)
Crucial role of transient receptor potential ankyrin 1 and mast cells in induction of nonallergic airway hyperreactivity in mice.American journal of respiratory and critical care medicine, 187 5
M. Wouters, M. Vicario, Javier Santos (2015)
The role of mast cells in functional GI disordersGut, 65
J. Bernstein (2013)
MP29-02: a breakthrough for the treatment of allergic rhinitisExpert Opinion on Pharmacotherapy, 14
J. Bernstein, B. Davis, Jillian Picard, Jennifer Cooper, Shu Zheng, L. Levin (2011)
A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 107 2
is recipient of a senior researcher fellowship from FWO. This study was supported by Meda Pharmaceuticals
B. Steelant, R. Farré, P. Wawrzyniak, J. Belmans, E. Dekimpe, H. Vanheel, L. Gerven, I. Krohn, D. Bullens, J. Ceuppens, C. Akdis, G. Boeckxstaens, S. Seys, P. Hellings (2016)
Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression.The Journal of allergy and clinical immunology, 137 4
I. Heijink, M. Jonker, M. Vries, A. Oosterhout, E. Telenga, N. Hacken, D. Postma, M. Berge (2016)
Budesonide and fluticasone propionate differentially affect the airway epithelial barrierRespiratory Research, 17
L. Gerven, Y. Alpizar, M. Wouters, V. Hox, E. Hauben, M. Jorissen, G. Boeckxstaens, K. Talavera, P. Hellings (2014)
Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis.The Journal of allergy and clinical immunology, 133 5
designed the study
and Lieve Coorevits for their technical assistance with ELISA measurements, flow cytometric analysis, and cell culture, respectively
C. Segboer, C. Holland, S. Reinartz, I. Terreehorst, A. Gevorgyan, P. Hellings, C. Drunen, W. Fokkens (2013)
Nasal hyper‐reactivity is a common feature in both allergic and nonallergic rhinitisAllergy, 68
P. Anand, K. Bley (2011)
Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patchBJA: British Journal of Anaesthesia, 107
L. Gerven, G. Boeckxstaens, M. Jorissen, W. Fokkens, P. Hellings (2012)
Short‐time cold dry air exposure: A useful diagnostic tool for nasal hyperresponsivenessThe Laryngoscope, 122
Henrik Jacobi, P. Skov, Lars Poulsen, H. Malling, Niels Mygind (1999)
Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine.The Journal of allergy and clinical immunology, 103 5 Pt 1
P. Demoly, M. Calderón, T. Casale, G. Scadding, I. Annesi-Maesano, J. Braun, B. Delaisi, Thierry Haddad, O. Malard, F. Trébuchon, É. Serrano (2013)
Assessment of disease control in allergic rhinitisClinical and Translational Allergy, 3
W. Carr, J. Bernstein, P. Lieberman, E. Meltzer, C. Bachert, D. Price, U. Munzel, J. Bousquet (2012)
A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.The Journal of allergy and clinical immunology, 129 5
I. Callebaut, A. Vries, B. Steelant, V. Hox, S. Bobic, L. Gerven, J. Ceuppens, P. Hellings (2014)
Nasal Allergen Deposition Leads to Conjunctival Mast Cell Degranulation in Allergic RhinoconjunctivitisAmerican Journal of Rhinology & Allergy, 28
D. Price, S. Shah, S. Bhatia, C. Bachert, W. Berger, J. Bousquet, W. Carr, P. Hellings, U. Munzel, G. Scadding, P. Lieberman (2013)
A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.Journal of investigational allergology & clinical immunology, 23 7
A. Catalli, V. Karpov, L. Erdos, B. Tancowny, R. Schleimer, M. Kulka (2014)
Stimulus-Selective Regulation of Human Mast Cell Gene Expression, Degranulation and Leukotriene Production by Fluticasone and SalmeterolPLoS ONE, 9
Umesh Singh, J. Bernstein, Lauren Haar, Kristin Luther, W. Jones (2014)
Azelastine Desensitization of Transient Receptor Potential Vanilloid 1: A Potential Mechanism Explaining its Therapeutic Effect in Nonallergic RhinitisAmerican Journal of Rhinology & Allergy, 28
P Demoly, PJ Bousquet, K Mesbah, J Bousquet, P Devillier (2013)
Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis, 43
Allergy – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.